Search Results - Rocha, Sony

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

    ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile by Kauder, Steven E, Kuo, Tracy C, Harrabi, Ons, Chen, Amy, Sangalang, Emma, Doyle, Laura, Rocha, Sony S, Bollini, Sangeetha, Han, Bora, Sim, Janet, Pons, Jaume, Wan, Hong I

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    867 TriTAC-XR is an extended-release T cell engager platform designed to minimize cytokine release syndrome by reducing Cmax in systemic circulation

    867 TriTAC-XR is an extended-release T cell engager platform designed to minimize cytokine release syndrome by reducing Cmax in systemic circulation by Kwant, Kathryn, Rocha, Sony, Stephenson, Katrina, Dayao, Maria, Thothathri, Subramanian, Banzon, Rose, Aaron, Wade, Hemmati, Golzar, Callihan, Evan, Yu, Timothy, O’Rear, Jessica, Bragg, Eric, Kwong, Willis, Situ, Hubert, Hundal, Avneel, Yu, Stephen, Jackson, Taggra, Wright, Kevin, Xiao, Yinghua, To, Linh, Austin, Richard, Lemon, Bryan, Wesche, Holger, Jack Lin, S

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors

    632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors by Lin, Jack, Rocha, Sony, Kwant, Kathryn, Dayao, Maria, Ng, Tessie, Aaron, Wade, Callihan, Evan, Gamez-Guerrero, Maria, Hemmati, Golzar, Wright, Kevin, Barath, Manasi, Xiao, Yinghua, Degree, Master, Yu, Timothy, Chew, Patrick, Evans, Thomas, O’Rear, Jessica, Gatto, Scott, Cremin, Michael, Yu, Stephen, Patnaik, Purbasa, Hundal, Avneel, Austin, Richard, Lemon, Bryan, Wesche, Holger

    Request full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 933: ProTriTAC is a modular and robust T cell engager prodrug platform with therapeutic index expansion observed across multiple tumor targets

    Abstract 933: ProTriTAC is a modular and robust T cell engager prodrug platform with therapeutic index expansion observed across multiple tumor targets by Lin, S. Jack, Rocha, Sony S., Kwant, Kathryn, Dayao, Maria Rosalyn, Ng, Tessie M., Banzon, Raphaela Rose, Thothathri, Subramanian, Aaron, Wade, Callihan, Evan, Hemmati, Golzar, Wright, Kevin J., Barath, Manasi, Xiao, Yinghua, To, Linh, Yu, Timothy, O'Rear, Jessica, Bragg, Eric, Gatto, Scott, Yu, Stephen, Patnaik, Purbasa, Hundal, Avneel, Austin, Richard J., Lemon, Bryan, Wesche, Holger

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models

    ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Pr... by Kauder, Steven E, Kuo, Tracy C, Chen, Amy, Harrabi, Ons, Rocha, Sony S, Doyle, Laura, Bollini, Sangeetha, Han, Bora, Sangalang, Emma Ruth B, Sim, Janet, Randolph, Sophia, Pons, Jaume, Wan, Hong I

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 5070: Anti-tumor activity of HPN328, a DLL3-targeting tri-specific, half-life extended T cell engager, is enhanced by combining with an anti-PD-L1 antibody in an immunocompetent mouse model

    Abstract 5070: Anti-tumor activity of HPN328, a DLL3-targeting tri-specific, half-life extended T cell engager, is enhanced by combining with an anti-PD-L1 antibody in an immunocom... by Valenzuela, Laura B., Wu, Chi-Heng, Aaron, Wade, Banzon, Raphalea R., Bush, Mabel, Lin, S. Jack, Rocha, Sony S., Thothathri, Subramanian, Wesche, Holger, Molloy, Mary Ellen, Anand, Banmeet S.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Abstract 2928: TROP2 ProTriTAC™, a protease-activated T cell engager prodrug targeting TROP2 for the treatment of solid tumors

    Abstract 2928: TROP2 ProTriTAC™, a protease-activated T cell engager prodrug targeting TROP2 for the treatment of solid tumors by Rocha, Sony S., Lin, Regina, Dayao, Maria R., Banzon, Raphaela Rose, Thothathri, Subramanian, Wright, Kevin J., Aaron, Wade, Xiao, Yinghua, Bergo, Nick, To, Linh, Bush, Mabel, Barath, Manasi, Yu, Timothy, Kwong, Willis, Situ, Hubert, Bragg, Eric, O'Rear, Jessica, Carlin, Kevin, Yu, Stephen, Solorio, Maritza, Lemon, Bryan, Austin, Richard, Wesche, Holger, Lin, S. Jack

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Abstract 2927: ITGB6 ProTriTAC™, a protease-activated T cell engager prodrug targeting Integrin-β6 for the treatment of solid tumors

    Abstract 2927: ITGB6 ProTriTAC™, a protease-activated T cell engager prodrug targeting Integrin-β6 for the treatment of solid tumors by Lin, Regina J., Rocha, Sony S., Dayao, Maria R., Thothathri, Subramanian, Banzon, Raphaela Rose, Wright, Kevin J., Aaron, Wade, Xiao, Yinghua, Bergo, Nick, To, Linh, Bush, Mabel, Barath, Manasi, Yang, Yi, Yu, Timothy, Kwong, Willis, Situ, Hubert, Bragg, Eric, O'Rear, Jessica, Carlin, Kevin, Yu, Stephen, Solorio, Maritza, Lemon, Bryan, Austin, Richard, Wesche, Holger, Lin, S. Jack

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Abstract 2861: TriTAC-XR: An extended-release T cell engager platform designed to minimize cytokine release syndrome

    Abstract 2861: TriTAC-XR: An extended-release T cell engager platform designed to minimize cytokine release syndrome by Kwant, Kathryn Strobel, Rocha, Sony S., Yu, Timothy, Stephenson, Katrina, Banzon, Raphaela Rose, Vollhardt, Sydney, Hemmati, Golzar, Callihan, Evan, Aaron, Wade H., Thothathri, Subramanian, O'Rear, Jessica, Bragg, Eric, Kwong, Willis, Situ, Hubert, Hundal, Avneel, Yu, Stephen, Jackson, Taggra, Carlin, Kevin, Xiao, Yinghua, Dayao, Maria Rosalyn, To, Linh, Bergo, Nick, Wright, Kevin, Austin, Richard, Wesche, Holger, Lemon, Bryan, Lin, S. Jack

    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

    ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile by Kauder, Steven E, Kuo, Tracy C, Harrabi, Ons, Chen, Amy, Sangalang, Emma, Doyle, Laura, Rocha, Sony S, Bollini, Sangeetha, Han, Bora, Sim, Janet, Pons, Jaume, Wan, Hong I

    Published in PLoS ONE
    Get full text
    Report
    Save to List
    Saved in:
  11. 11
    ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

    ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile by Kauder, Steven E, Kuo, Tracy C, Harrabi, Ons, Chen, Amy, Sangalang, Emma, Doyle, Laura, Rocha, Sony S, Bollini, Sangeetha, Han, Bora, Sim, Janet, Pons, Jaume, Wan, Hong I

    Published in PLoS ONE
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: